Matthew Bullard Overview

  • Primary Position
  • Managing Directo...

  • Primary Industry
  • Healthcare

  • Med. Deal Size

Matthew Bullard General Information

Biography

Mr. Matthew Bullard served as Managing Director at HealthCare Royalty Partners. He served as a Partner at NovaQuest Capital Management. He has over 13 years of experience investing in the healthcare industry. His role as Principal of NovaQuest Capital Management, LLC involves developing, structuring, and negotiating investments in the healthcare industry. From the formation of the NovaQuest business unit at Quintiles through 2010, Mr. Bullard served as the Head of Investment Analytics. In this role, he was responsible for pricing, financial modeling, structuring, and negotiating the NovaQuest business unit's product-based and company investments with a variety of biopharmaceutical companies. Mr. Bullard also played a material role in committing greater than $1.4 billion in gross capital to the NovaQuest business unit's investment transactions. Prior to joining Quintiles, Mr. Bullard was a Financial Analyst with Jefferson Pilot Financial in North Carolina.

Contact Information

Primary Position
Managing Director, HealthCare Royalty Partners
Education
University of North Carolina, Chapel Hill, MBA (Master of Business Administration)
University of North Carolina, Chapel Hill, BS (Bachelor of Science)
Gender
Male
Email
ma

Matthew Bullard Lead Partner on Deals (4)

Matthew Bullard has been the lead partner on 4 deals. Their latest deal was with Arvelle Therapeutics, a drug discovery company. The deal was made for on 26-May-2020.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Arvelle Therapeutics 26-May-2020 Early Stage VC (Series A) Completed Drug Discovery Zug, Switzerland
Nevakar Injectables 18-Jun-2019 Completed Drug Delivery Bridgewater, NJ
Dermavant Sciences 28-Aug-2018 PE Growth/Expansion Completed Biotechnology Long Beach, CA
Mesoblast 02-Jul-2018 PIPE Completed Biotechnology Melbourne, Australia

Matthew Bullard Network (41)

Portfolio Executives (41)

Name Company Role Deal date Location
Gregory Weinhoff MD Arvelle Therapeutics Co-Founder, Chief Business Officer and Chief Financial Officer 26-May-2020 Zug, Switzerland
Ilise Lombardo MD Arvelle Therapeutics Co-Founder & Chief Medical Officer 26-May-2020 Zug, Switzerland
Nevakar Injectables Chief Medical Affairs Officer 18-Jun-2019 Bridgewater, NJ
Nevakar Injectables Corporate Advisor 18-Jun-2019 Bridgewater, NJ
Nevakar Injectables Chief Scientific Officer 18-Jun-2019 Bridgewater, NJ

Matthew Bullard Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
NovaQuest Co-Investment Fund VI NovaQuest Capital Management Co-Investment Closed 2017
NovaQuest Pharma Opportunities Fund V NovaQuest Capital Management Direct Lending Closed 2019

Matthew Bullard FAQs

  • Who is Matthew Bullard?

    Mr. Matthew Bullard served as Managing Director at HealthCare Royalty Partners.

  • How much does Matthew Bullard typically invest?

    Matthew Bullard's median deal size is .

  • What is Matthew Bullard’s main position?

    Matthew Bullard’s primary position is Managing Director.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »